Associated with reduced circulating frequencies of functionally exhausted PD-1 positive CD4+ and CD8+ T cells, Mannick et al. demonstrated a significantly enhanced serological response to influenza vaccination in older adults treated with the allosteric mammalian target of rapamycin (mTOR) inhibitor RAD001 prior to antigenic challenge (292). Here, MTOR is linked to influenza.